HomeTagsHuman papillomavirus

Tag: human papillomavirus

Featured Image: Genmab's bioreactor laboratory. Photo Courtesy: 2020 Genmab.

Positive Phase II Trial Results for Tisotumab Vedotin Cervical Cancer

ADC Review | Editorial Team
The phase II innovaTV 204 trial, a single-arm clinical trial also known as GCT1015-04 or GOG-3023/ENGOT-cx6 (NCT03438396), evaluating tisotumab vedotin administered every three weeks...

Phase II Trial of Tisotumab Vedotin in Advanced Cervical Cancer Provides...

Peter Hofland
Genmab and Seattle Genetics confirmed their decision to start a Phase II study of tisotumab vedotin in patients with recurrent and/or metastatic cervical cancer....
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

MADE POSSIBLE BY
MabPlex

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.